| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Oct 03, 2017 | Option Exercise | $180.00 | 67,932 | 12,227,760 | 1,807 | Oct 05, 2017, 08:28 PM | |
| KITE | Kite Pharma, Inc. | CLARK IAN T | Director | Oct 03, 2017 | Option Exercise | $180.00 | 1,776 | 319,680 | 5,324 | Oct 05, 2017, 08:27 PM | |
| KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Oct 03, 2017 | Option Exercise | $180.00 | 2,553 | 459,540 | 1,807 | Oct 05, 2017, 08:25 PM | |
| KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Oct 03, 2017 | Option Exercise | $180.00 | 70,050 | 12,609,000 | 0 | Oct 05, 2017, 08:25 PM | |
| KITE | Kite Pharma, Inc. | Humer Franz B | Director | Oct 03, 2017 | Option Exercise | $180.00 | 4,624 | 832,320 | 1,807 | Oct 05, 2017, 08:24 PM | |
| KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Oct 03, 2017 | Option Exercise | $180.00 | 150,620 | 27,111,600 | 1,807 | Oct 05, 2017, 08:23 PM | |
| KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Oct 03, 2017 | Option Exercise | $180.00 | 25,065 | 4,511,700 | 0 | Oct 05, 2017, 08:23 PM | |
| KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Oct 03, 2017 | Option Exercise | $180.00 | 61,467 | 11,064,060 | 1,807 | Oct 05, 2017, 08:20 PM | |
| KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Oct 03, 2017 | Option Exercise | $180.00 | 58,535 | 10,536,300 | 5,715 | Oct 05, 2017, 08:19 PM | |
| KITE | Kite Pharma, Inc. | MOORE TIMOTHY L. | EVP, Technical Operations | Oct 03, 2017 | Option Exercise | $180.00 | 3,927 | 706,860 | 41,734 | Oct 05, 2017, 08:17 PM | |
| KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Officer | Oct 03, 2017 | Option Exercise | $180.00 | 16,135 | 2,904,300 | 39,933 | Oct 05, 2017, 08:16 PM | |
| KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Development | Oct 03, 2017 | Option Exercise | $180.00 | 14,674 | 2,641,320 | 11,150 | Oct 05, 2017, 08:15 PM | |
| KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Development | Oct 03, 2017 | Option Exercise | $180.00 | 4,193 | 754,740 | 17,500 | Oct 05, 2017, 08:14 PM | |
| KITE | Kite Pharma, Inc. | JENKINSON PAUL L | Chief Financial Officer | Oct 03, 2017 | Option Exercise | $180.00 | 3,000 | 540,000 | 0 | Oct 05, 2017, 08:13 PM | |
| KITE | Kite Pharma, Inc. | Chang David D | EVP, R&D, Chief Medical Off. | Oct 03, 2017 | Option Exercise | $180.00 | 16,605 | 2,988,900 | 38,675 | Oct 05, 2017, 08:12 PM | |
| KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President and CEO | Oct 03, 2017 | Option Exercise | $180.00 | 3,197,269 | 575,508,420 | 0 | Oct 05, 2017, 08:10 PM | |
| KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Officer | Sep 25, 2017 | Sale | $179.66 | 4,203 | 755,128 | 61,068 | Sep 27, 2017, 09:44 PM | |
| KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Development | Sep 25, 2017 | Sale | $179.66 | 3,171 | 569,715 | 21,693 | Sep 27, 2017, 09:43 PM | |
| KITE | Kite Pharma, Inc. | MOORE TIMOTHY L. | EVP, Technical Operations | Mar 15, 2017 | Sale | $83.31 | 7,511 | 625,741 | 41,889 | Sep 27, 2017, 09:42 PM | |
| KITE | Kite Pharma, Inc. | MOORE TIMOTHY L. | EVP, Technical Operations | Sep 25, 2017 | Sale | $179.66 | 4,228 | 759,619 | 45,661 | Sep 27, 2017, 09:42 PM | |
| KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Development | Sep 25, 2017 | Sale | $179.66 | 5,283 | 949,165 | 25,824 | Sep 27, 2017, 09:41 PM | |
| KITE | Kite Pharma, Inc. | Chang David D | EVP, R&D, Chief Medical Off. | Sep 25, 2017 | Sale | $179.66 | 7,927 | 1,424,197 | 57,423 | Sep 27, 2017, 09:40 PM | |
| KITE | Kite Pharma, Inc. | JENKINSON PAUL L | Chief Financial Officer | Sep 25, 2017 | Sale | $179.66 | 948 | 170,321 | 9,462 | Sep 27, 2017, 09:39 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Sep 25, 2017 | Sale | $179.66 | 4,228 | 759,619 | 121,567 | Sep 27, 2017, 09:38 PM | |
| KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President and CEO | Sep 25, 2017 | Sale | $179.66 | 26,347 | 4,733,607 | 109,160 | Sep 27, 2017, 09:38 PM | |
| KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Development | Aug 10, 2017 | Option Exercise | $86.47 | 12,502 | 1,081,051 | 24,915 | Aug 14, 2017, 05:04 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Aug 10, 2017 | Sale | $61.03 | 30,000 | 1,831,008 | 132,795 | Aug 14, 2017, 05:03 PM | |
| KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Development | Aug 08, 2017 | Sale | $86.73 | 159,898 | 13,867,575 | 98,613 | Aug 10, 2017, 04:57 PM | |
| KITE | Kite Pharma, Inc. | MOORE TIMOTHY L. | EVP, Technical Operations | Aug 03, 2017 | Sale | $77.48 | 12,000 | 929,803 | 55,400 | Aug 04, 2017, 07:50 PM | |
| KITE | Kite Pharma, Inc. | MOORE TIMOTHY L. | EVP, Technical Operations | Aug 01, 2017 | Sale | $95.14 | 15,000 | 1,427,052 | 61,400 | Aug 03, 2017, 09:14 PM | |
| KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Development | Jul 31, 2017 | Sale | $81.12 | 53,298 | 4,323,709 | 45,313 | Aug 01, 2017, 07:00 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Jul 10, 2017 | Sale | $52.22 | 30,000 | 1,566,550 | 132,795 | Jul 11, 2017, 05:36 PM | |
| KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Development | Jul 03, 2017 | Sale | $55.61 | 20,000 | 1,112,101 | 31,071 | Jul 06, 2017, 06:15 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Jun 23, 2017 | Sale | $51.08 | 10,000 | 510,783 | 122,795 | Jun 27, 2017, 07:07 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Jun 23, 2017 | Sale | $100.81 | 5,000 | 504,033 | 114,845 | Jun 27, 2017, 12:25 PM | |
| KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Jun 23, 2017 | Sale | $59.00 | 25,000 | 1,475,000 | 101,250 | Jun 26, 2017, 07:55 PM | |
| KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Jun 26, 2017 | Sale | $100.60 | 12,500 | 1,257,500 | 76,250 | Jun 26, 2017, 07:55 PM | |
| KITE | Kite Pharma, Inc. | Ruchefsky Steven B | Director | Jun 14, 2017 | Sale | $89.48 | 20,000 | 1,789,574 | 205,426 | Jun 16, 2017, 05:43 PM | |
| KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Jun 16, 2017 | Sale | $88.11 | 5,450 | 480,200 | 0 | Jun 16, 2017, 05:41 PM | |
| KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Jun 14, 2017 | Sale | $90.40 | 15,000 | 1,356,000 | 63,664 | Jun 16, 2017, 05:41 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Jun 09, 2017 | Sale | $44.95 | 20,000 | 898,991 | 127,795 | Jun 12, 2017, 07:16 PM | |
| KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Jun 07, 2017 | Sale | $84.46 | 10,000 | 844,621 | 155,017 | Jun 09, 2017, 09:11 PM | |
| KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Jun 08, 2017 | Sale | $84.53 | 5,000 | 422,634 | 150,017 | Jun 09, 2017, 09:11 PM | |
| KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Development | Jun 01, 2017 | Sale | $61.94 | 4,800 | 297,312 | 21,064 | Jun 05, 2017, 05:05 PM | |
| KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | May 09, 2017 | Buy | $69.11 | 9,832 | 679,474 | 3,520 | May 11, 2017, 02:02 PM | |
| KITE | Kite Pharma, Inc. | JENKINSON PAUL L | Chief Financial Officer | May 10, 2017 | Buy | $72.57 | 450 | 32,656 | 7,480 | May 10, 2017, 03:12 PM | |
| KITE | Kite Pharma, Inc. | JENKINSON PAUL L | Chief Financial Officer | May 10, 2017 | Buy | $72.59 | 3,000 | 217,770 | 3,000 | May 10, 2017, 03:12 PM | |
| KITE | Kite Pharma, Inc. | Ruchefsky Steven B | Director | May 09, 2017 | Buy | $69.50 | 1,400 | 97,300 | 225,426 | May 10, 2017, 12:52 PM | |
| KITE | Kite Pharma, Inc. | BONDERMAN DAVID | Director | May 09, 2017 | Buy | $68.94 | 50,000 | 3,446,997 | 2,408,084 | May 09, 2017, 06:29 PM | |
| KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President and CEO | May 09, 2017 | Buy | $68.57 | 17,000 | 1,165,690 | 85,507 | May 09, 2017, 03:37 PM | |
| KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Development | May 01, 2017 | Option Exercise | $68.01 | 4,800 | 326,448 | 21,064 | May 03, 2017, 06:08 PM | |
| KITE | Kite Pharma, Inc. | Chang David D | EVP, R&D, Chief Medical Off. | May 01, 2017 | Sale | $44.49 | 40,000 | 1,779,544 | 70,165 | May 03, 2017, 06:06 PM | |
| KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Apr 27, 2017 | Sale | $82.77 | 16,551 | 1,369,926 | 7,579 | May 01, 2017, 06:52 PM | |
| KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Apr 28, 2017 | Sale | $82.59 | 2,617 | 216,138 | 4,962 | May 01, 2017, 06:52 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Apr 25, 2017 | Sale | $41.60 | 30,000 | 1,247,940 | 132,795 | Apr 27, 2017, 06:49 PM | |
| KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Apr 24, 2017 | Sale | $82.34 | 25,818 | 2,125,854 | 122,225 | Apr 26, 2017, 05:38 PM | |
| KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Apr 25, 2017 | Sale | $82.80 | 46,783 | 3,873,585 | 90,758 | Apr 26, 2017, 05:38 PM | |
| KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Apr 26, 2017 | Sale | $82.72 | 51,312 | 4,244,597 | 24,330 | Apr 26, 2017, 05:38 PM | |
| KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Apr 13, 2017 | Sale | $82.39 | 72,275 | 5,954,737 | 191,144 | Apr 17, 2017, 09:24 PM | |
| KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Apr 17, 2017 | Sale | $82.48 | 43,101 | 3,555,029 | 148,143 | Apr 17, 2017, 09:24 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Apr 03, 2017 | Sale | $41.65 | 10,000 | 416,548 | 122,795 | Apr 04, 2017, 04:15 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Mar 27, 2017 | Sale | $39.51 | 20,000 | 790,246 | 127,795 | Mar 28, 2017, 07:57 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Mar 09, 2017 | Sale | $41.07 | 42,236 | 1,734,438 | 138,913 | Mar 10, 2017, 05:25 PM | |
| KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Development | Mar 01, 2017 | Sale | $40.95 | 36,000 | 1,474,164 | 39,071 | Mar 02, 2017, 06:09 AM | |
| KITE | Kite Pharma, Inc. | Chang David D | EVP, R&D, Chief Medical Off. | Mar 01, 2017 | Option Exercise | $43.02 | 120,000 | 5,162,841 | 110,165 | Mar 02, 2017, 06:08 AM | |
| KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Mar 01, 2017 | Sale | $18.98 | 66,000 | 1,252,373 | 121,017 | Mar 02, 2017, 06:06 AM | |
| KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Mar 01, 2017 | Sale | $76.76 | 2,800 | 214,942 | 25,065 | Mar 02, 2017, 06:06 AM | |
| KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Development | Feb 28, 2017 | Sale | $59.83 | 95,800 | 5,732,127 | 66,564 | Mar 02, 2017, 06:05 AM | |
| KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Development | Mar 01, 2017 | Sale | $64.67 | 4,800 | 310,399 | 21,064 | Mar 02, 2017, 06:05 AM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Feb 27, 2017 | Sale | $27.88 | 20,000 | 557,678 | 127,795 | Mar 01, 2017, 09:59 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Mar 01, 2017 | Option Exercise | $40.70 | 57,764 | 2,350,995 | 146,677 | Mar 01, 2017, 09:59 PM | |
| KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Development | Feb 01, 2017 | Option Exercise | $29.05 | 3,000 | 87,155 | 22,195 | Feb 06, 2017, 04:36 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Jan 31, 2017 | Sale | $25.95 | 20,000 | 519,062 | 127,795 | Feb 01, 2017, 07:09 PM | |
| KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Development | Jan 06, 2017 | Sale | $28.44 | 3,000 | 85,335 | 22,195 | Jan 10, 2017, 05:04 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Jan 06, 2017 | Sale | $25.74 | 20,000 | 514,789 | 127,795 | Jan 10, 2017, 05:03 PM | |
| KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Development | Dec 20, 2016 | Sale | $50.86 | 716 | 36,416 | 15,095 | Dec 22, 2016, 04:53 PM | |
| KITE | Kite Pharma, Inc. | Tomasello Shawn | Chief Commercial Officer | Dec 20, 2016 | Sale | $50.86 | 4,901 | 249,265 | 49,635 | Dec 22, 2016, 04:52 PM | |
| KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Development | Dec 20, 2016 | Sale | $50.86 | 936 | 47,605 | 8,064 | Dec 22, 2016, 04:51 PM | |
| KITE | Kite Pharma, Inc. | Chang David D | EVP, R&D, Chief Medical Off. | Dec 20, 2016 | Sale | $50.86 | 1,788 | 90,938 | 25,123 | Dec 22, 2016, 04:50 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Dec 20, 2016 | Sale | $50.86 | 2,482 | 126,235 | 92,995 | Dec 22, 2016, 04:48 PM | |
| KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President and CEO | Dec 20, 2016 | Sale | $50.86 | 3,493 | 177,654 | 24,707 | Dec 22, 2016, 04:47 PM | |
| KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Development | Dec 01, 2016 | Sale | $28.82 | 3,000 | 86,469 | 17,311 | Dec 05, 2016, 07:03 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Nov 25, 2016 | Sale | $25.88 | 20,000 | 517,515 | 105,477 | Nov 29, 2016, 05:02 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Nov 10, 2016 | Sale | $26.00 | 20,000 | 519,966 | 105,477 | Nov 14, 2016, 06:57 PM | |
| KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Development | Nov 10, 2016 | Sale | $28.54 | 3,000 | 85,605 | 17,311 | Nov 14, 2016, 06:55 PM | |
| KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Development | Oct 03, 2016 | Sale | $30.85 | 3,000 | 92,549 | 17,311 | Oct 05, 2016, 07:44 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Sep 26, 2016 | Option Exercise | $27.74 | 20,000 | 554,800 | 105,477 | Sep 28, 2016, 05:03 PM | |
| KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Development | Sep 01, 2016 | Sale | $32.57 | 3,000 | 97,697 | 17,311 | Sep 02, 2016, 06:34 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Aug 25, 2016 | Sale | $29.81 | 20,000 | 596,275 | 105,477 | Aug 26, 2016, 06:38 PM | |
| KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Development | Aug 12, 2016 | Sale | $55.75 | 67,000 | 3,735,501 | 42,500 | Aug 16, 2016, 08:16 PM | |
| KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Development | Aug 15, 2016 | Sale | $57.22 | 4,800 | 274,661 | 11,400 | Aug 16, 2016, 08:16 PM | |
| KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Development | Aug 01, 2016 | Sale | $31.89 | 3,000 | 95,678 | 16,367 | Aug 02, 2016, 06:51 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Jul 25, 2016 | Option Exercise | $26.14 | 20,000 | 522,850 | 105,401 | Jul 26, 2016, 07:03 PM | |
| KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Development | Jul 01, 2016 | Option Exercise | $28.45 | 3,000 | 85,342 | 16,367 | Jul 05, 2016, 06:27 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Jun 23, 2016 | Option Exercise | $26.31 | 20,000 | 526,254 | 105,401 | Jun 27, 2016, 07:08 PM | |
| KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Officer | Jun 27, 2016 | Option Exercise | $25.75 | 20,000 | 514,984 | 105,401 | Jun 27, 2016, 07:08 PM | |
| KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Jun 06, 2016 | Sale | $58.38 | 4,000 | 233,516 | 27,865 | Jun 08, 2016, 07:27 PM | |
| KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Jun 06, 2016 | Sale | $57.91 | 10,000 | 579,065 | 136,017 | Jun 08, 2016, 07:27 PM | |
| KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Development | May 31, 2016 | Sale | $28.44 | 3,000 | 85,335 | 16,367 | Jun 02, 2016, 05:15 PM | |
| KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Development | Jun 01, 2016 | Sale | $29.09 | 3,000 | 87,284 | 16,367 | Jun 02, 2016, 05:15 PM |
Menu